Concepedia

Publication | Closed Access

NVP-BEZ235 as a New Therapeutic Option for Sarcomas

DOI

148

Citations

25

References

2010

Year

Maria Cristina Manara, Giordano Nicoletti, Diana Zambelli, Selena Ventura, Clara Guerzoni, Lorena Landuzzi, Pier‐Luigi Lollini, Saveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Mario Mercuri,
Clinical Cancer Research

Abstract

NVP-BEZ235 displays the features to be considered for sarcoma therapy to potentiate the activity of other anticancer agents. The drug is currently undergoing phase I/II clinical trials in advanced cancer patients.

References

YearCitations

Page 1